… form of lung cancer and attracts the lion’s share of the research funding, recent developments in small cell lung … In order to capitalize on these recent developments, researchers who focus on small cell lung cancer (SCLC) will … (FDA) approved the immunotherapy nivolumab for SCLC. The research supporting that FDA recommendation, the  Checkmate …

… “Lung Cancer Considered.” Those interested in lung cancer research and clinical developments can now tune in to "Lung Cancer Considered" twice each month for the latest research and news on the study of lung cancer. "Lung Cancer Considered" will feature the researchers, healthcare professionals, patients and advocates …

… participants for the Supportive Training for Advocates on Research and Science (STARS) Program to attend the IASLC 2019 … a new program that aims to increase the number of Patient Research Advocates (PRAs) equipped to provide accurate … and to provide the patient perspective for lung cancer research and policy. Of the ten participants, there are 5 …

… a multidisciplinary approach, the JTO includes original research, review articles, and opinion pieces. The audience … its strength is in its multidisciplinary approach to research, JTO will continue its emphasis on multidisciplinary research to serve the broad community working in thoracic …

… was awarded the Mary J. Matthews Pathology & Transitional Research Award today at the 2022 IASLC World Conference on … Lung Cancer. The Mary J. Matthews Pathology/Translational Research Award recognizes an IASLC scientist for lifetime achievement in pathology and translational research of thoracic malignancies. Dr. Matthews served as a …

… Award, honoring her lifetime scientific achievements in research on the prevention of thoracic malignancies. Dr. … is also senior scientist at the International Prevention Research Institute and co-founder of the World Cancer Alliance … from the region together to facilitate collaborative research and education on lung cancer prevention, early …

… on Lung Cancer, today presented awards to clinicians and researchers who made significant contributions to the fight … The awards represent many major categories of lung cancer research, from tumor staging to tobacco control and smoking … Cancer -- Dr. Trudy Oliver, USA, Pharmacology and Cancer Research Nurses and Allied Health Professionals Award (Nurses …

… for the position of Editor-in-Chief for JTO Clinical and Research Reports (JTO CRR). Dr. Alex A. Adjei will step down … of JTO CRR in October, 2022. Through a global search, IASLC is seeking to appoint his successor for a … journal, and an excellent international network amongst researchers are other key factors on which candidates will be …

… 12, 2021--Articles published in the JTO Clinical and Research Reports  (JTO CRR) are now indexed and available … which come from thousands of journals. JTO Clinical and Research Reports  articles are available at … publishing model to promptly publish cutting-edge research. As an open-access journal, articles are immediately …

… Spain September 9, 2025 1 p.m. CEST / UTC +2) — New research presented identifies interferon-induced transmembrane … resistance to PD-1/PD-L1 checkpoint blockade. The research was presented at the International Association for … I (MHC-I), which impairs immune recognition and response. Researchers from the Shanghai Pulmonary Hospital and the …

… Award, honoring his lifetime scientific achievements in research on the prevention of thoracic malignancies. Dr. Khuri … at Emory University School of Medicine. Dr. Khuri’s research in the development of prognostic, molecular and … molecular oncologist, Dr. Khuri has directed pivotal research on oncolytic viral therapy, molecular-targeted …

… in stage IV diagnoses among EGFR+ patients, according to research presented today at the International Association for … Conference on Lung Cancer.  The International Agency for Research on Cancer (IARC) categorized outdoor air pollution … cancer account for a majority of lung cancers. Still, researchers and public health experts have not been able to …